CancerVax Passes First Test with Flying Colors
December 20, 2024 03:01 ET
|
CancerVAX, Inc
Lehi, Utah, Dec. 20, 2024 (GLOBE NEWSWIRE) -- CancerVax Passes First Test with Flying Colors Recent in-vitro lab results confirm that the Company’s Smart mRNA can be used as a potential on/off...
CancerVax Targets Hard to Treat Pancreatic Cancer
December 11, 2024 12:48 ET
|
CancerVAX, Inc
Lehi, UT, Dec. 11, 2024 (GLOBE NEWSWIRE) -- CancerVax Targets Hard to Treat Pancreatic Cancer With limited options available to treat Pancreatic Ductal Adenocarcinoma (PDAC), the Company’s...
CancerVax Lands Top Cancer Expert
November 19, 2024 03:15 ET
|
CancerVAX, Inc
Lehi, Utah, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Dr. George Katibah to serve as the Company’s Chief Scientific Officer Lehi, UT, November 19, 2024 (GLOBE NEWSWIRE) -- CancerVax, Inc., the developer of...
CancerVax Taps Flashpoint Therapeutics’ Nanotechnology Platform to Drive Universal Cancer Treatment
August 29, 2024 03:01 ET
|
CancerVAX, Inc
Santa Barbara, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Santa Barbara, CA, August 29, 2024 (GLOBE NEWSWIRE) -- CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform that will...
CancerVax Files New Patent for Its Novel Universal Cancer Treatment Platform
August 27, 2024 03:01 ET
|
CancerVAX, Inc
Santa Barbara, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Santa Barbara, CA, August 27, 2024 (GLOBE NEWSWIRE) -- CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform that will...
CancerVax Adds Key Members to Its Research Team
August 01, 2024 03:01 ET
|
CancerVAX, Inc
Santa Barbara, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Santa Barbara, CA, August 1, 2024 (GLOBE NEWSWIRE) -- CancerVax, Inc., the developer of breakthrough cancer drugs that will use the body’s immune...
CancerVax Successfully Uses Nobel Prize Chemistry to Achieve Universal Cancer Vaccine Targeting Milestone
May 21, 2024 03:00 ET
|
CancerVAX, Inc
Santa Barbara, May 21, 2024 (GLOBE NEWSWIRE) -- Santa Barbara, CA, May 21, 2024 (GLOBE NEWSWIRE) -- CancerVax, Inc., the developer of breakthrough cancer drugs that will use the body’s immune system...
CancerVax Announces Promising New Drug to Treat a Deadly Children’s Cancer
April 16, 2024 03:01 ET
|
CancerVAX, Inc
Santa Barbara, April 16, 2024 (GLOBE NEWSWIRE) -- Santa Barbara, CA, April 16, 2024 (GLOBE NEWSWIRE) -- CancerVax, Inc., the developer of breakthrough cancer drugs that will use the body’s immune...
CancerVax Launches $5 Million Funding Round
April 03, 2024 03:01 ET
|
CancerVAX, Inc
Lehi, Utah, April 03, 2024 (GLOBE NEWSWIRE) -- CancerVax, Inc., developer of a breakthrough Universal Cancer Vaccine treatment that will use the body’s immune system to fight cancer, today announced...
CancerVAX CEO Ryan Davies Discusses Cancer Drug Development with Dr. Ezra Cohen
November 02, 2023 09:08 ET
|
CancerVAX, Inc
LEHI, Utah, Nov. 02, 2023 (GLOBE NEWSWIRE) -- CancerVAX, Inc., developer of a breakthrough universal cancer vaccine that uses the body’s immune system to fight cancer, today announced that in a...